Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily).
Rivastigmine patch in Chinese patients with probable Alzheimer's disease : a 24-week randomised, double blind parallel group study that compared Rivastigmine patch (9.5 mg/24 h) with a capsule (6 mg twice daily).